NCT01548235: Observational Safety Study in Subjects With Type 2 Diabetes Mellitus Starting or Switching to Biphasic Insulin Aspart 30 Treatment |
|
|
| Completed | N/A | 423 | Europe | biphasic insulin aspart 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2 | 04/07 | 04/07 | | |
NCT00715663: Observational Study to Evaluate Safety, Efficacy and Convenience of Using NovoMix® 30 FlexPen® in Type 2 Diabetes |
|
|
| Completed | N/A | 1584 | RoW | biphasic insulin aspart 30, NovoMix® 30 | Novo Nordisk A/S | Diabetes, Diabetes Mellitus, Type 2, Delivery Systems | 12/07 | 12/07 | | |
